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Abdominal aortic aneurysm and abdominal wall hernia
as manifestations of a connective tissue disorder
George A. Antoniou, MD,a,b George S. Georgiadis, MD,a Stavros A. Antoniou, MD,c
Frank A. Granderath, MD,c Athanasios D. Giannoukas, MD, PhD, EBSQvasc,b and
Miltos K. Lazarides, MD, EBSQvasc,a Alexandroupolis and Larissa, Greece; and Mönchengladbach, Germany
Background: Abdominal aortic aneurysms (AAAs) and abdominal wall hernias represent chronic degenerative conditions.
Both aortic aneurysms and inguinal hernias share common epidemiologic features, and several investigators have found
an increased propensity for hernia development in patients treated for aortic aneurysms. Chronic inflammation and
dysregulation in connective tissue metabolism constitute underlying biological processes, whereas genetic influences
appear to be independently associated with both disease states. A literature review was conducted to identify all published
evidence correlating aneurysms and hernias to a common pathology.
Methods: PubMed/Medline was searched for studies investigating the clinical, biochemical, and genetic associations of
AAAs and abdominal wall hernias. The literature was searched using the MeSH terms “aortic aneurysm, abdominal,”
“hernia, inguinal,” “hernia, ventral,” “collagen,” “connective tissue,” “matrix metalloproteinases,” and “genetics” in all
possible combinations. An evaluation, analysis, and critical overview of current clinical data and pathogenic mechanisms
suggesting an association between aneurysms and hernias were undertaken.
Results: Ample evidence lending support to the clinical correlation between AAAs and abdominal wall hernias exists. Pooled
analysis demonstrated that patients undergoing aortic aneurysm repair through a midline abdominal incision have a 2.9-fold
increased risk of developing a postoperative incisional hernia compared with patients treated for aortoiliac occlusive disease
(odds ratio, 2.86; 95% confidence interval, 1.97-4.16; P < .00001), whereas the risk of inguinal hernia was 2.3 (odds ratio,
2.30; 95% confidence interval, 1.52-3.48;P< .0001). Emerging evidence has identified inguinal hernia as an independent risk
factor for aneurysm development. Although mechanisms of extracellular matrix remodeling and the imbalance between
connective tissue degrading enzymes and their inhibitors instigating inflammatory responses have separately been described for
both disease states, comparative studies investigating these biological processes in aneurysm and hernia populations are scarce.
A genetic predisposition has been documented in familial and observational segregation studies; however, the pertinent
literature lacks sufficient supporting evidence for a common genetic basis for aneurysm and hernia.
Conclusions: Insufficient data are currently available to support a systemic connective tissue defect affecting the
structural integrity of the aortic and abdominal wall. Future investigations may elucidate obscure aspects of
aneurysm and hernia pathophysiology and create novel targets for pharmaceutical and gene strategies for disease
prevention and treatment. ( J Vasc Surg 2011;54:1175-81.)
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wall hernias constitute significant health problems creat-
ing substantial social and financial burdens for health and
surgical services in several countries. Similar epidemio-
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doi:10.1016/j.jvs.2011.02.065ogic features for AAAs and inguinal hernias have been
escribed, with both conditions largely affecting males
f increasing age with a history of smoking and/or
hronic obstructive pulmonary disease.1,2 Furthermore,
he clinical correlation between aneurysms and hernias is
ell documented, and increasing evidence suggests that
atients with AAAs have a great propensity for abdomi-
al wall hernias.3
The pathogenesis of aneurysmal disease of the aorta
nd abdominal wall herniation is complex and multifac-
orial. Current concepts converge on the fact that a
ysregulation in connective tissue metabolism is respon-
ible for the clinical manifestation of aneurysm or her-
ia.4-8 However, even though mechanisms of imbalance
f collagen synthesis and degradation have been de-
cribed for both clinical conditions, no unified biological
heory to link aneurysms and hernias to a common
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October 20111176 Antoniou et alpathology has been proposed. Identification of common
underlying pathogenic mechanisms may give further in-
sight into the biological processes of disease develop-
ment and have implications in clinical practice such as
selective aneurysm screening in high-risk hernia popula-
tions and a pharmacotherapeutic potential.
The objective of this article was to identify all published
evidence correlating AAAs and abdominal wall hernias at
the clinical, biochemical, and genetic level. An evaluation,
analysis, and critical overview of current supporting data
linking these conditions to common pathogenic biological
processes is being undertaken.
METHODS
PubMed/Medline was searched for studies investi-
gating the clinical, biochemical, and genetic associations
of AAAs and abdominal wall hernias. The literature was
searched using the MeSH terms “aortic aneurysm, ab-
dominal,” “hernia, inguinal,” “hernia, ventral,” “colla-
gen,” “connective tissue,” “matrix metalloproteinases,”
and “genetics” in all possible combinations. Search of
the electronic databases was conducted from 1966 to the
present day, and the reference lists of related articles were
also manually extracted and collected as part of a second-
level search. Retrieved articles were categorized as those
correlating aneurysm and hernia at the clinical, biochem-
ical, and genetic level. Eighty-eight relevant English
language articles were identified, of which 17 were spe-
cifically investigating the association of AAAs and ab-
dominal wall hernias. An evaluation, analysis, and critical
overview of current clinical data and pathogenic mecha-
nisms suggesting an association between aneurysms and
hernias are being undertaken. A meta-analysis of studies
comparing the incidence of postoperative incisional her-
nias and inguinal hernias in patients undergoing AAA
repair and aortoiliac occlusive disease reconstruction
through a midline incision was conducted. Study-specific
estimates were combined using random-effects models
or fixed-effects models as appropriate. The presence of
Study DOAAAA
 n/N  n/N
 Stevick   et al       10/27               4/39 
 Hall et al       13/128              2/65 
 Holland et al       18/56               6/31 
Adye and Luna       18/58               5/42 
 Musella et al       16/51              11/63 
 Papadimitriou et al        7/63               2/58 
 Raffetto       50/177              9/82 
 Liapis et al       32/197              5/67 
Total (95% CI) 757                447
Total events: 164 (AAA), 44 (AOD)
Test for heterogeneity: Chi² = 2.07, df = 7 (P = .96), I² = 0%
Test for overall effect: Z = 5.54 (P < .00001)
 0.1
 Favo
Fig 1. Meta-analysis of studies comparing the inciden
aneurysms (AAAs) and aortoiliac occlusive disease (AODbetween-study heterogeneity was assessed using the Co- .hrane I2 test. The statistical package used was the free
ersion of RevMan 4.2, The Cochrane Collaboration.
ESULTS
linical correlation between aneurysm and hernia
Aneurysm and incisional hernia. The initial pre-
umption that an independent relationship exists between
AAs and incisional hernias formation has been docu-
ented by several reports.9-18 Comparative studies evalu-
ting the incidence of postoperative incisional hernias re-
ort values ranging between 10% and 37% for patients
reated for AAAs, and 3% and 19% for those having aor-
oiliac reconstruction for occlusive disease. An updated
eta-analysis of published reports found that patients who
ad a midline laparotomy for AAA repair had a 2.9-fold
ncreased risk of developing postoperative incisional hernia
ompared with those with aortoiliac occlusive disease (odds
atio [OR], 2.86; 95% confidence interval [CI], 1.97-4.16;
 .00001; Fig 1). This difference persisted even after
djusting for confounding variables, which could poten-
ially affect the outcome.3
Some authors have proposed prophylactic mesh wound
losure to reduce the risk of ventral hernias.19 A random-
zed clinical trial confirmed the significant effect of routine
esh placement after open aortic aneurysm reconstruction
n the incidence of incisional hernia compared with su-
ured wound closure.20 Conclusions drawn from previous
tudies have raised the hypothesis that a structural defect in
ortic and abdominal wall connective tissue might exist,
ccounting for aneurysmal degeneration of the aorta and
ostoperative incisional hernia formation.
Aneurysm and inguinal hernia. Reported prevalences
f inguinal hernias range between 19% and 41% for patients
ith a history of AAA repair, whereas values for nonaneu-
ysm patients range between 5% and 27%.11,13-16,21-23
ooled analysis of these studies demonstrated that patients
reated for AAAs have a 2.3-fold increased risk of inguinal
ernia development compared with aortoiliac occlusive
isease reconstruction (OR, 2.30; 95% CI, 1.52-3.48; P 
)dexif(RO  OR (fixed)
raeYIC%59IC%59
5.15 [1.41, 18.82] 1988
3.56 [0.78, 16.28]  1995
1.97 [0.69, 5.66]  1996
3.33 [1.12, 9.87] 1998
2.16 [0.90, 5.21]  2001
3.50 [0.70, 17.59]  2002
3.19 [1.48, 6.87] 2003
2.40 [0.90, 6.45] 2004
     2.86 [1.97, 4.16]
 0.5  1  2  5  10
 Favors  AOD
f incisional hernias in patients with abdominal aortic
I, Confidence interval; OR, odds ratio. 0.2
rs  AAA
ce o0001; Fig 2). A reverse link has also been identified,
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Volume 54, Number 4 Antoniou et al 1177constituting inguinal hernia as an independent risk factor
for AAAs.24,25 Research conducted in our institution has
found that male patients with inguinal hernia have a four-
fold increased prevalence of AAAs compared with control
subjects without hernias.26
Mechanisms of connective tissue metabolism for
aneurysm and hernia formation
Pathogenesis and biology of AAAs. Aneurysms re-
sult from a chronic degenerative process that evolves over a
long period of time. The National Heart, Lung, and Blood
Institute defined current areas of research focusing on
proteolytic degradation of the aortic wall connective tissue
as well as inflammatory and immunologic responses as the
main culprits of the pathogenic mechanisms of AAA forma-
tion.4,5 Important structural elements of the aortic wall are
elastin and collagen, found in the arterial media and adven-
titia providing passive strength to the wall, whereas medial
smooth muscle cells define its active properties. Elastin is
the main component of the media and provides and distrib-
utes tensile strength along the arterial wall. It is synthesized
during the early stages of aortic wall development and has
an estimated half-life of 60 years. Solid evidence exists
supporting that elastin degradation occurs in the early
stages of the pathogenic process of aneurysm develop-
ment.26-28 Collagen is the primary structural element of the
adventitia, and unlike elastin, is under a continuous process
of synthesis and degradation through life. It provides stiff-
ness to the arterial wall. A report found increased collagen
and a prominent inflammatory cell infiltration in the aneu-
rysm wall compared with nonaneurysmal aortas.29 In-
creased collagenolytic activity in the aneurysmal aorta being
correlated with aneurysm size has been demonstrated in
another report.30 It seems that collagen synthesis in-
creases during the early stage of aneurysm formation;
however, at later stages, degradation exceeds synthesis,
resulting in continuing aneurysm expansion and, ulti-
mately, rupture.29-31 The aortic wall extracellular matrix
is a complex structure, which apart from its scaffold
*Subjects from AAA screening program. 
Study DOAAAA
 n/N  n/N
 Cannon et al       88/341             61/417 
 Lehnert et al       49/119             15/81 
 Hall et al               28/128             11/65 
Adye and Luna       11/58               2/42 
 Musella et al       20/51              13/63 
 Papadimitriou et al       21/63               6/58 
 Raffetto et al       42/177              5/82 
 Colledge et al      266/873           2883/10872*
Total (95% CI) 1810               11680
Total events: 525 (AAA), 2996 (AOD)
Test for heterogeneity: Chi² = 27.92, df = 7 (P = .0002), I² = 74.9%
Test for overall effect: Z = 3.95 (P < .0001)
 0.1
 Favo
Fig 2. Meta-analysis of studies reporting on the risk of
(AAAs) and controls. AOD, Aortoiliac occlusive diseaseproperties to the aortic wall, exerts a number of biolog- tcal activities and regulates elastin and collagen synthesis
nd degradation, smooth muscle cell apoptosis, che-
otaxis and cell migration, inflammation and immune
esponses, and angiogenesis.
There is ample evidence that matrix degradation by a
ariety of proteolytic enzymes, mainly matrix metallopro-
einases (MMPs), is integral to aneurysm development, and
hat an imbalance between MMPs and their inhibitors
TIMPs) impairs normal physiological aortic wall remodel-
ng.32 Elastolysis is an early event in aneurysm formation.
reestone et al demonstrated that MMP-2 was the domi-
ant gelatinase in small aneurysms, suggesting that it is the
nciting enzyme in aneurysm genesis.33 As opposed to
MP-2, McMillan et al found higher MMP-9 mRNA
xpression in moderate-diameter (5-6.9 cm) than small-
iameter (4 cm) aneurysms.34 Evidence suggests that
MP-9 is the dominant proteolytic enzyme promoting
ontinued expansion and rupture.34,35 Several other
MPs have been demonstrated to play a role in the aneu-
ysm degrading and inflammatory process (Table). Regu-
ation of MMP activity is achieved at different levels, with
IMPs having been suggested as an important regulator of
xtracellular matrix degradation. The balance of aortic wall
emodeling between MMPs and their inhibitors favors
ollagen and elastin degradation. However, the initiating
vents and the mechanisms for propagating these proteo-
ytic enzymes in the aortic wall remain to be identified.
Investigations have also demonstrated a significant im-
unologic contribution to the pathogenesis of the disease.
t seems that exogenous and/or endogenous factors dis-
upting the intima/adventitia and exposing elastin and
nterstitial collagen instigate an immune response resulting
n a cascade of inflammatory events.36,37 Immune cells,
ncluding macrophages and lymphocytes, along with
mooth muscle cells and fibroblasts promote a strong in-
ammatory reaction, which activates proteolytic enzymes
nd extracellular matrix degradation. Elastin and collagen
egradation products, in turn, propagate a sequestered
nflammatory reaction, leading to further degeneration of
)modnar(RO  OR (random)
raeYIC%59IC%59
2.03 [1.41, 2.92] 1984
3.08 [1.58, 6.01]  1992
1.37 [0.64, 2.97]  1995
4.68 [0.98, 22.38] 1998
2.48 [1.08, 5.69]  2001
4.33 [1.60, 11.71]  2002
4.79 [1.82, 12.62] 2003
1.21 [1.04, 1.41] 2008
     2.30 [1.52, 3.48]
 0.5  1  2  5  10
 Favors AOD
inal hernia in patients with abdominal aortic aneurysms
confidence interval; OR, odds ratio. 0.2
rs AAA
inguhe aortic wall, aneurysm expansion, and rupture. Oxidative
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inflammation. Zhang et al demonstrated increased expres-
sion of inducible nitric oxide synthase in the aneurysm wall
tissues as compared with normal aorta.38 The integral part
of the whole process is a reduction inmedial smoothmuscle
cells (apoptosis), which are the principal cell type produc-
ing extracellular matrix components.39 It seems however,
that during life, as oxidative stress increases and more and
more assaults occur at the endothelial and smooth muscle
levels, there is a natural biological anti-inflammatory pro-
cess that counteracts the tendency toward inflammatory
degradation.
Understanding of the significance of MMPs in biology
and pathology has led to the development of numerous
potent synthetic inhibitors of MMPs. Such agents may be
of great therapeutic value, and some of them are in clinical
trials for the treatment of cancer and inflammatory condi-
tions.40 Tetracyclins nonselectively inhibit MMPs via
mechanisms similar to those of endogenous inhibitors and
have been shown to effectively prevent elastin and collagen
destruction and aneurysmal dilatation.41
Pathogenesis and biology of abdominal wall hernias.
Hernia has historically been considered to be caused by
structural defects in the integrity of the abdominal wall,
which may result from various intrinsic or exogenous trig-
gering factors.2 Current concepts put forward the premise
Table. Role of MMPs in the pathogenesis of aneurysm an
MMP Enzyme
Genetic
location
Main extracel
substr
MMP-1 Collagenase 1 11q22-q23 Collagens (I, II
VIII, X), gela
fibronectin, v
laminin, aggr
MMP-2 Gelatinase A 16q13 Collagens (I, II
VII, X, XI), g
fibronectin, v
laminin
MMP-3 Stromelysin 1 11q23 Collagens (III,
IX, X, XI), ge
fibronectin, v
laminin
MMP-8 Collagenase 2 11q21-q22 Collagens (I, II
aggrecan
MMP-9 Gelatinase B 20q11.2-q13.1 Collagens (IV, V
gelatin, elasti
laminin, aggr
MMP-12 Macrophage
elastase
11q22.2-q22.3 Collagens (I, IV
elastin, fibron
vitronectin, la
MMP-13 Collagenase 3 11q22.3 Collagens (I, II
IX, X, XIV),
fibronectin, a
MMP-14 MT1-MMP 14q11-q12 Collagens (I, II
fibronectin, t
vitronectin, la
MMP, Matrix metalloproteinase.that hernia development is a biological process.6-8 There is mufficient evidence to suggest that the underlying etiologies
re associated with disturbances in connective tissuemetab-
lism and impaired extracellular matrix turnover.
Collagen is the predominant structural protein of the
bdominal fascial layers and the main component of the
xtracellular matrix. Type I and Type III are those collagen
ypes implicated in abdominal wall hernia formation. Type
collagen represents highly cross-linked mature collagen
hat confers mechanical strength to fascial tissues, whereas
ype III collagen is less cross-linked, consists of thinner
bers, and provides less strength to the tissues. In healthy
issues, extracellular matrix is under a dynamic process of
ynthesis and degradation. An imbalance in collagen ho-
eostasis expressed as either delayed or abnormal collagen
ynthesis or increased proteolytic collagen breakdown has
een found to have a causal effect on herniogenesis.8
An altered collagen structure and disordered collagen
ype I/Type III ratio have been demonstrated by several
nvestigators in fascia connective tissue of both patients
ith inguinal and incisional hernias.42-47 The decreased
ype I/Type III collagen ratio in the connective tissue of
atients with abdominal wall hernias may be attributed to
ither a primary defect in collagen synthesis or altered
ollagen degradation caused by inordinate extracellular
atrix activity. The degrading limb of the dynamic homeo-
tatic process of collagen metabolism has been evaluated by
nia
matrix Role in aortic
aneurysm
Role in abdominal
wall hernia
VII,
ctin,
Collagenolysis, associated
with risk of rupture
Increased activity in
recurrent inguinal
hernia
IV, V,
, elastin,
ctin,
Elastolysis, dominant role
in early stages of
aneurysm formation
Dominant role in
direct inguinal
hernia
, VII,
elastin,
ctin,
Elastin and collagen
degradation, activates
other pro-MMPs,
angiogenesis
—
Collagen degradation,
aneurysm rupture
—
, XIV),
onectin,
Elastolysis, collagenolysis,
dominant role in later
stages of aneurysm
formation and rupture
Overexpression in
inguinal hernia
gelatin,
,
n
Elastolytic activity —
IV, VI,
n,
an
Collagenolysis, associated
with risk of rupture
Role in recurrent
inguinal hernia
gelatin,
in,
n
Activates pro-MMP-2 Activates pro-MMP-2,
increased expression
in direct/indirect
inguinal herniad her
lular
ates
, III,
tin,
itrone
ecan
, III,
elatin
itrone
IV, V
latin,
itrone
, III),
, XI
n, vitr
ecan
, V),
ectin
mini
, III,
gelati
ggrec
, III),
enasc
minieasuring the levels of MMPs in abdominal wall fascial
g
i
h
t
l
a
m
A
s
(
h
a
t
p
c
n
h
m
i
s
c
t
m
e
t
d
a
C
a
t
h
t
s
i
t
a
t
p
o
h
m
i
i
m
l
o
d
m
n
m
d
JOURNAL OF VASCULAR SURGERY
Volume 54, Number 4 Antoniou et al 1179layers.48 Several studies have demonstrated an MMP-2
overexpression in both transversalis fascia and skin fibro-
blasts from patients with direct inguinal hernias compared
with controls.43,49,50 Research conducted in our institu-
tion demonstrated an imbalance ofMMP/TIMP activity at
both the local tissue level and systemic circulation, indicat-
ing a dysregulation of the extracellular matrix degradation
process.51 Furthermore, several authors have shown an
association between MMP-1 and MMP-13 activity and
recurrent inguinal and incisional hernia, suggesting a dis-
turbed process of wound healing as their underlying etiol-
ogy (Table).42,44-46 Inflammation is an integral part of
wound repair and hernia formation, as shown by inflamma-
tory cells marginating into injured tissue and cytokines and
growth factors propagating inflammatory reactions in injured
connective and wound-healing tissues.6 Rosch et al found
increased connective tissue-like growth factor in recurrent
inguinal hernia patients, which promotes angiogenesis, in-
flammation, proliferation, and collagen synthesis.46
Common pathogenic mechanisms of collagen me-
tabolism for aneurysm and hernia. Both AAAs and ab-
dominal wall hernias are characterized by an increased pro-
teolytic activity and disruption of protease/antiprotease
balance. This, in turn, results in an abnormal connective tissue
remodeling process, with disorganized collagen synthesis and
enhanced degradation. Inflammation is an important feature
in the pathologic process of both conditions.
There is evidence to presume that a defect in connective
tissue metabolism is a systemic process. This presumption is
supported by initial findings of increased serum proteolytic
activity in smokers with direct inguinal hernia and a similar
imbalance in smokers with AAAs.21 Furthermore, several
investigators have demonstrated elevated circulating levels
of MMPs, which reflect the dynamic and heterogeneous
nature of extracellular matrix metabolism. Plasma MMP-9
levels have been found to be higher in patients with AAAs
than those in patients with aortoiliac occlusive disease.52,53
Patients with inguinal hernias have recently been demon-
strated to have increased plasma MMP-2 activity.54 Theo-
retically, highly expressed metalloproteinase at the local
tissue level could be continuously released into the systemic
circulation and bemeasurable in the plasma of patients with
aneurysms and hernias.
Genetic aspects of aneurysm and hernia
Genetic influences appear to be independently associated
with both disease states. A genetic predisposition to AAA
development has been documented by both familial and seg-
regation observational studies.55-57 Baird et al found an aneu-
rysm prevalence of 19% in siblings of patients with AAAs as
compared with 8% in controls using ultrasound examina-
tion.56 Thompson et al have undertaken a meta-analysis of all
aneurysm candidate gene analysis studies and identified three
polymorphisms associated with a significant risk of aneurysm
(ACE relative risk [RR], 1.33 [95% CI, 1.20-1.48], MTHFR
RR, 1.14 [1.08-1.21], andMMP-9RR, 1.09 [1.01-1.18]).58
Polymorphic sites and gene mutations of proteins of the
structural components of the connective tissue (elastin, colla- ten), extracellular matrix degrading enzymes and their inhib-
tors (MMPs, TIMPs) and inflammation promotion agents
ave separately been investigated in gene association observa-
ional studies. Nevertheless, no single gene has yet been iso-
ated as the key factor interpreting the genetic basis of aortic
neurysms. A small number of families have genetically deter-
inedType III collagen defect (COL3A1), inwhich cases the
AA is considered to be a manifestation of Ehlers-Danlos
yndrome.59 Furthermore, mutations in the fibrilin-1 gene
15q21.1) are responsible for Marfan syndrome, which is a
ereditary connective tissue disorder associated with thoraco-
bdominal aortic aneurysms and dissections.60
The ultimate etiology of abdominal wall hernia seems
o be underlined by the contribution of genetic, intrinsic
atient-related and extrinsic environmental factors. A re-
ent case-control study evaluating the risk factors for ingui-
al hernias suggested the familial component of inguinal
ernias as the most important risk factor.61 Genetic abnor-
alities of extracellular matrix constituents are character-
zed by a high risk of inguinal hernia. Of these, Marfan
yndrome and Ehlers-Danlos syndrome are genetically and
linically heterogenous conditions, which involve both ar-
erial aneurysms and abdominal wall hernias in their clinical
anifestations.62,63 However, no gene association studies
xist investigating the role of polymorphic sites and muta-
ions of other components integral to the connective tissue
egradation and inflammatory process in patients with
neurysms and hernia disease.
ONCLUSIONS AND FUTURE PERSPECTIVE
Sufficient clinical evidence exists to connect AAAs and
bdominal wall hernias to a common pathology. However,
he underlying pathogenic mechanisms of this relationship
ave not been explained in full. Even though there appears
o be a systemic disorder affecting collagen and elastin
ynthesis and degradation, no studies exist to compare and
nvestigate the biological processes in abdominal wall fascial
issues and/or aortic wall tissue in patients with hernias and
neurysms. Furthermore, no gene association studies inves-
igating their common genetic background have ever been
erformed. Whole genome studies may define subgroups
f patients at risk for developing both aneurysms and
ernias.
Further knowledge on common underlying pathogenic
echanisms and genetic influences might have significant
mplications in clinical practice. Demonstrating of abdom-
nal wall hernia as an independent risk factor for AAAs
ight warrant selective screening in these high-risk popu-
ations. Additionally, targeted approaches with the design
f specific inhibitors of key players in the connective tissue
egeneration process might provide novel pharmacologic
ethods of deceleration of aneurysm progression and her-
ia development and recurrence. Further knowledge about
echanisms of regulation of MMP gene expression may
irect therapeutic strategies toward tissue-targeted gene
herapies with agents that selectively inhibit specificMMPs.
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